Appetite regulation
GLP-1 and GIP receptor engagement to support satiety signalling and reduced caloric drive.
Product · ZythaLabs
Retatrutide FastPen® 40mg
Triple-agonist weight-loss peptide in a calibrated pre-filled injection pen — precision dosing with German manufacturing.
For use under qualified clinical guidance. See FAQs below for storage and handling.
Retatrutide FastPen® is an advanced metabolic peptide platform designed for consistent subcutaneous delivery of a GLP-1 / GIP / glucagon triple agonist — with clinical clarity in every calibrated dose.
Built on emerging metabolic research, FastPen supports pathways associated with:
Metabolic flexibility
Glucagon pathway activity that may support energy expenditure and fat mobilisation.
Dose precision
Four pre-measured 10mg units in one pen — consistent delivery without reconstitution.
Company
Mission, vision & values
Mission
Deliver pharmaceutical-grade peptide systems that clinics and informed partners can trust — precise dosing, transparent specifications, and German manufacturing standards.
Vision
Advance metabolic care through science-led delivery devices — education, safety, and accessible innovation without marketing noise.
Brand values
- Science-based
- Quality & purity
- Dose accuracy
- Clinical clarity
- Responsible access
- Continuous innovation
FastPen® 40mg
Retatrutide FastPen
One device. Four calibrated doses. Built for professionals who need consistency from first unit to last.
- Triple agonist pathway — engages GLP-1, GIP and glucagon receptors in a single molecule.
- Pre-filled convenience — no mixing, no vial drawing; ready for clinical workflows.
- Calibrated dosing — four × 10mg units with clear unit indication.
- Metabolic support focus — designed around weight-management protocols.
- German manufacture — produced to exacting European quality standards.
- Clinic-ready packaging — presentation that communicates trust at a glance.
- Direct delivery — subcutaneous format for reliable systemic exposure vs oral peptides.
How to use
Instructions
Follow clinic guidance. These steps outline typical FastPen handling for trained users.
-
01
Remove cap & attach needle
Remove the outer pen cap. Attach a fresh sterile needle by twisting firmly onto the cartridge tip.
-
02
Prime the pen
Dial a small priming amount. Point upward and press until a drop appears at the needle tip.
-
03
Select your dose
Dial the prescribed unit amount. Confirm the dose window before proceeding.
-
04
Choose injection site
Clean abdomen or outer thigh with an alcohol swab. Allow the site to dry fully.
-
05
Inject subcutaneously
Pinch skin gently, insert at 90°, press fully and hold briefly before withdrawing.
-
06
Remove & dispose
Remove the needle into a sharps container. Replace the cap and store as directed.
Reviews
What partners say
Feedback from clinics and informed users evaluating FastPen presentation and handling.
The FastPen format removed reconstitution friction from our workflow. Dose windows are clear and packaging feels pharmaceutical-grade.
Patients appreciate the cleaner presentation versus multi-vial setups. Training time dropped noticeably in the first fortnight.
Straightforward to use after clinic instruction. Four doses in one pen is exactly what I needed for a structured protocol.
Delivery was prompt and cold-chain packaging gave confidence from the first open. Support answered storage questions the same day.
Impeccable packaging and clear labelling. The pen dial feels precise — no guesswork on units.
Zytha’s documentation matched what my clinician expected. I would recommend FastPen for anyone already cleared for peptide therapy.
Why FastPen
Key benefits
Designed around metabolic pathways and practical clinical delivery.
Appetite signalling
Supports satiety pathways via GLP-1 and GIP receptor engagement.
Energy expenditure
Glucagon activity may aid metabolic rate and fat utilisation.
Protocol consistency
Calibrated units reduce dose variability across a treatment course.
Clinic efficiency
Pre-filled design shortens prep time versus vial reconstitution.
Quality assurance
German manufacturing with batch-oriented quality controls.
Clear presentation
Labelling and packaging built for professional environments.
Support
FAQs
Common questions about Retatrutide FastPen® 40mg.
What is Retatrutide FastPen®?
A pre-filled injection pen containing Retatrutide 40mg total, delivered as four calibrated 10mg doses. It is designed for subcutaneous use under appropriate clinical guidance.
How is this different from oral peptides?
Oral peptides are often degraded in the gut with limited bioavailability. Subcutaneous delivery bypasses digestion for more reliable systemic exposure when used as directed.
How many doses are in each pen?
Each FastPen® 40mg contains four × 10mg units. Always confirm the dialled dose in the window before injecting.
Is the injection painful?
Most users describe a brief mild pinch similar to a standard insulin-style injection when an appropriate fine needle is used. Technique and needle gauge matter — follow clinic instruction.
Do I need a prescription or clinician oversight?
Peptide therapies should only be used under qualified medical supervision. Consult your healthcare provider before starting any metabolic peptide protocol.
How should I store the pen?
Store refrigerated as directed on the pack (typically 2–8°C unless otherwise stated). Do not freeze. Keep capped, away from direct light, and out of reach of children.
Quality
German manufacturing
Zytha Labs partners with European production standards focused on purity, dose accuracy, and supply integrity.
Quality & compliance
Process controls aligned with pharmaceutical presentation expectations.
Traceability
Batch-oriented documentation for supply-chain accountability.
Innovation
Ongoing refinement of peptide delivery formats and packaging.
Patient-centricity
Clear instructions and clinic-ready design for safer handling.